A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancerTim Meyer, Hiroki Kato, Justin S. Waters et al.|European Journal of Cancer|2009Cited by 39